Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Since receiving FDA approval in 2001, Deflux® has enabled thousands of children to receive a highly effective, minimally invasive, same-day treatment for VUR. Deflux has revolutionized the treatment...
-
SANTA BARBARA, Kalifornien och STOCKHOLM, Sverige, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Palette Life Sciences, ett helt integrerat life sciencebolag med huvudkontor i Sverige, som verkar för att...
-
SURREY, British Columbia, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Pushfor Investments Inc. (CSE: PUSH, OTC: PUSOF, FSX: 713) (the “Company” or “Pushfor”) is pleased to announce that it has closed the...
-
HOUSTON, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported third-quarter 2021 results and provided the following...
-
HOUSTON, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and...
-
Henderson, NV, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Legends Business Group, Inc. (OTC Pink: LGBS) (“LGBS”) is excited to announce the acquisition of North Star Developers from AAP, Inc. (OTC Pink:...
-
Newark, NJ, Oct. 25, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global high tibial osteotomy (HTO) plates market is expected to grow from USD 88.12 million in 2020 and...
-
Dublin, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The "Bone Cement Mixer Devices Market Research Report by Type, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has...
-
Publication immédiate – 8 octobre 2021 Louvain-la-Neuve, Belgique, 8 octobre 2021 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et...
-
DEVON, Pa., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and...